DK126426B - Analogifremgangsmåde til fremstilling af hydroxylaminderivater eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af hydroxylaminderivater eller syreadditionssalte deraf.

Info

Publication number
DK126426B
DK126426B DK172369AA DK172369A DK126426B DK 126426 B DK126426 B DK 126426B DK 172369A A DK172369A A DK 172369AA DK 172369 A DK172369 A DK 172369A DK 126426 B DK126426 B DK 126426B
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
analogous process
hydroxylamine derivatives
Prior art date
Application number
DK172369AA
Other languages
English (en)
Inventor
L Kisfaludy
L Dancsi
A Patthy
L Szporny
L Doemoek
E Karpati
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK126426B publication Critical patent/DK126426B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK172369AA 1968-03-30 1969-03-28 Analogifremgangsmåde til fremstilling af hydroxylaminderivater eller syreadditionssalte deraf. DK126426B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000343 1968-03-30

Publications (1)

Publication Number Publication Date
DK126426B true DK126426B (da) 1973-07-16

Family

ID=11000825

Family Applications (1)

Application Number Title Priority Date Filing Date
DK172369AA DK126426B (da) 1968-03-30 1969-03-28 Analogifremgangsmåde til fremstilling af hydroxylaminderivater eller syreadditionssalte deraf.

Country Status (10)

Country Link
US (1) US3642805A (da)
JP (1) JPS4843726B1 (da)
AT (2) AT296252B (da)
CH (1) CH510620A (da)
DE (1) DE1916481C3 (da)
DK (1) DK126426B (da)
FR (1) FR2007354B1 (da)
GB (1) GB1240224A (da)
NL (1) NL6904889A (da)
SE (1) SE375760B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322987A (en) * 1969-12-29 1973-07-11 Richter Gedeon Vegyeszet On,n-diacylhydroxylamine derivatives and preparation
US4028401A (en) * 1976-07-01 1977-06-07 Morton-Norwich Products, Inc. (Substituted)ureidoacetohydroxamic acids
US4496541A (en) * 1983-01-12 1985-01-29 Usv Pharmaceutical Corporation Compounds for treating hypertension
JPS6321067U (da) * 1986-07-26 1988-02-12
US5228899A (en) * 1989-08-25 1993-07-20 Sumitomo Chemical Company Limited Hydroxamic acid esters and plant growth regulation therewith
US5254724A (en) * 1991-10-30 1993-10-19 University Of Florida Research Foundation, Inc. Method for synthesis of desferrioxamine B, analogs and homologs thereof
DE10007308A1 (de) * 2000-02-17 2001-08-23 Bosch Gmbh Robert Verfahren und Vorrichtung zur Ermittlung der verbleibenden Betriebsdauer eines Produktes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1167934A (fr) * 1955-06-28 1958-12-03 Hoffmann La Roche Procédé pour la préparation de nouveaux dérivés d'alpha-amino-beta-hydroxy-acides

Also Published As

Publication number Publication date
DE1916481A1 (de) 1969-10-09
NL6904889A (da) 1969-10-02
SE375760B (da) 1975-04-28
AT296252B (de) 1972-02-10
US3642805A (en) 1972-02-15
DE1916481C3 (de) 1974-06-27
JPS4843726B1 (da) 1973-12-20
DE1916481B2 (de) 1973-11-29
GB1240224A (en) 1971-07-21
FR2007354B1 (da) 1974-01-11
AT293358B (de) 1971-10-11
CH510620A (de) 1971-07-31
FR2007354A1 (da) 1970-01-09

Similar Documents

Publication Publication Date Title
DK124884B (da) Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf.
DK124547B (da) Analogifremgangsmåde til fremstilling af (3-amino-2-hydroxy-propyloxy)-thiochromanderivater eller syreadditionssalte deraf.
DK122879B (da) Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK120996B (da) Analogifremgangsmåde til fremstilling af piperidinderivater eller syreadditionssalte deraf.
DK135278B (da) Analogifremgangsmåde til fremstilling af fenoksyisopropanolaminderivater eller syreadditionssalte deraf.
DK132411B (da) Analogifremgangsmåde til fremstilling af pyrrylaminoketonderivater eller syreadditionssalte deraf.
DK125798B (da) Analogifremgangsmåde til fremstilling af pyridazinderivater eller syreadditionssalte heraf.
DK119059B (da) Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf.
DK127644B (da) Analogifremgangsmåde til fremstilling af ergopeptiner eller syreadditionssalte deraf.
DK126426B (da) Analogifremgangsmåde til fremstilling af hydroxylaminderivater eller syreadditionssalte deraf.
DK125245B (da) Fremgangsmåde til fremstilling af γpiperidinobutyrophenonderivater eller syreadditionssalte deraf.
DK126327B (da) Analogifremgangsmåde til fremstilling af derivater af p-aminoalkylbenzensulfonamid eller syreadditionssalte deraf.
DK120155B (da) Analogifremgangsmåde til fremstilling af aminopropiofenoner eller syreadditionssalte deraf.
DK129924B (da) Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf.
DK125472B (da) Analogifremgangsmåde til fremstilling af pyrimidopyridazinderivater eller syreadditionssalte deraf.
DK122323B (da) Fremgangsmåde til fremstilling af 1-alkyl-(eller alkenyl)-2-aminomethylpyrrolidiner eller syreadditionssalte heraf.
DK125129B (da) Analogifremgangsmåde til fremstilling af oximderivater eller syreadditionssalte deraf.
DK112524B (da) Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf.
DK137834B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepinderivater eller syreadditionssalte deraf.
DK124614B (da) Fremgangsmåde til fremstilling af 3-(3-piperidino- eller morpholinopropionyl)-5-phenylisoxazolderivater eller syreadditionssalte deraf.
DK124028B (da) Analogifremgangsmåde til fremstilling af quinolylformiminoethere eller syreadditionssalte deraf.
DK121375B (da) Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf.
DK131570B (da) Analogifremgangsmåde til fremstilling af thienylalkanderivater eller syreadditionssalte deraf.
DK122877B (da) Analogifremgangsmåde til fremstilling af fenylisopropylalkylaminderivater eller syreadditionssalte deraf.
DK125323B (da) Analogifremgangsmåde til fremstilling af derivater af sulfanilamid eller syreadditionssalte deraf.